Samabriva

Executive Summary

Samabriva is a French biotechnology company pioneering a plant-based bioproduction platform utilizing proprietary hairy root culture technology. This automated, contained system enables cost-effective, sustainable, and scalable manufacturing of high-value molecules, including secondary metabolites and recombinant proteins, targeting the biopharmaceutical and API markets. By offering an alternative to traditional extraction and fermentation methods, Samabriva addresses critical industry needs for reduced costs, environmental sustainability, and supply chain resilience. While the company remains private with limited public information on funding or stage, its innovative approach positions it to capture demand in the growing plant-based bioproduction sector, particularly for complex biologics and rare natural compounds. The company's Paris base and focus on respiratory and digital health intersections further underscore its niche in precision medicine and controlled environment production.

Upcoming Catalysts (preview)

• Q3 2026Strategic Partnership with Biopharma Company60% success
• Q2 2026Series A Financing Round Close70% success
• Q4 2026Technology Milestone: Scalable Production of Recombinant Protein50% success